|
DE3612211A1
(de)
|
1986-04-11 |
1987-10-15 |
Basf Ag |
Kontinuierliches verfahren zum tablettieren
|
|
DE19710008A1
(de)
*
|
1997-03-12 |
1998-09-17 |
Basf Ag |
Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
|
|
DE69917618T2
(de)
|
1998-04-03 |
2005-06-23 |
Egalet A/S |
Zusammensetzung mit kontrollierter wirkstoff-freisetzung
|
|
US7141250B2
(en)
|
2001-08-06 |
2006-11-28 |
Euro-Celtique S.A. |
Pharmaceutical formulation containing bittering agent
|
|
WO2003024430A1
(en)
|
2001-09-21 |
2003-03-27 |
Egalet A/S |
Morphine polymer release system
|
|
DE10252667A1
(de)
|
2002-11-11 |
2004-05-27 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
EP2186510B1
(en)
|
2003-03-26 |
2013-07-10 |
Egalet Ltd. |
Matrix compositions for controlled delivery of drug substances
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
ATE365545T1
(de)
|
2003-08-06 |
2007-07-15 |
Gruenenthal Gmbh |
Gegen missbrauch gesicherte darreichungsform
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
DE10360792A1
(de)
|
2003-12-23 |
2005-07-28 |
Grünenthal GmbH |
Spirocyclische Cyclohexan-Derivate
|
|
PL1740156T3
(pl)
|
2004-04-22 |
2011-12-30 |
Gruenenthal Gmbh |
Sposób wytwarzania zabezpieczonej przed nadużyciem, stałej postaci aplikacyjnej
|
|
WO2006002884A1
(de)
|
2004-07-01 |
2006-01-12 |
Grünenthal GmbH |
Gegen missbrauch gesicherte, orale darreichtungsform
|
|
PL1765298T3
(pl)
|
2004-07-01 |
2013-01-31 |
Gruenenthal Gmbh |
Sposób wytwarzania stałej postaci dawkowania, która jest zabezpieczona przez nadużywaniem, wykorzystujący wytłaczarkę z przekładnią planetarną
|
|
KR101204657B1
(ko)
|
2004-07-01 |
2012-11-27 |
그뤼넨탈 게엠베하 |
(1r,2r)-3-(3-디메틸아미노-1-에틸-2-메틸-프로필)-페놀을 함유하는 남용 방지 경구 투여 제형
|
|
JP4563787B2
(ja)
*
|
2004-12-10 |
2010-10-13 |
日立プラズマディスプレイ株式会社 |
プラズマディスプレイ装置及びその制御方法
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
WO2006128471A2
(en)
|
2005-06-03 |
2006-12-07 |
Egalet A/S |
A solid pharmaceutical composition with a first fraction of a dispersion medium and a second fraction of a matrix, the latter being at least partially first exposed to gastrointestinal fluids
|
|
US20090022798A1
(en)
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20100172989A1
(en)
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
AU2007205866B2
(en)
*
|
2006-01-21 |
2012-11-29 |
Abbott Gmbh & Co. Kg |
Dosage form and method for the delivery of drugs of abuse
|
|
CA2674536C
(en)
|
2007-01-16 |
2016-07-26 |
Egalet A/S |
Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
EP2061587A1
(en)
|
2007-04-26 |
2009-05-27 |
Sigmoid Pharma Limited |
Manufacture of multiple minicapsules
|
|
NZ580972A
(en)
|
2007-06-04 |
2012-02-24 |
Egalet Ltd |
Controlled release pharmaceutical compositions for prolonged effect
|
|
JP5774853B2
(ja)
|
2008-01-25 |
2015-09-09 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
医薬投薬形
|
|
MX339867B
(es)
|
2008-10-27 |
2016-06-14 |
Alza Corp * |
Forma de dosificacion oral de liberacion prolongada de acetaminofeno/tramadol.
|
|
NZ594071A
(en)
|
2009-01-26 |
2013-01-25 |
Egalet Ltd |
Controlled release formulations comprising morphine sulphate for continuous treatment of pain
|
|
WO2010088911A1
(en)
|
2009-02-06 |
2010-08-12 |
Egalet A/S |
Pharmaceutical compositions resistant to abuse
|
|
EP2445487A2
(en)
|
2009-06-24 |
2012-05-02 |
Egalet Ltd. |
Controlled release formulations
|
|
BR112012001547A2
(pt)
*
|
2009-07-22 |
2016-03-08 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica extrusada por fusão a quente
|
|
PL2838512T3
(pl)
*
|
2012-04-18 |
2018-12-31 |
Grünenthal GmbH |
Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
|
|
US10064945B2
(en)
*
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|